Lapatinib will raise the level or outcome of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Drug Formulary facts is intended to be used by Health care professionals. It's not necessarily intended to be health care suggestions. Several of the data, which includes specifics of funding for cancer medicine, https://ddrtrk189900.livebloggs.com/32885696/2-fundamentals-explained